Toremifene as a reference drug in the treatment of breast cancer

被引：0
|
作者：
Tarutinov, V.
机构：
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(08)70250-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P18
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [31] Cost of drug treatment for breast cancer in Ukraine
    Hryniv, O
    Kovalchuk, I
    Shparik, J
    Bilynsky, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 71 - 71
  • [32] DRUG-TREATMENT OF BREAST-CANCER
    DAVIS, TE
    CARBONE, PP
    DRUGS, 1978, 16 (05) : 441 - 464
  • [33] Targeted Drug Delivery for Breast Cancer Treatment
    Jin, Sha
    Ye, Kaiming
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2013, 8 (02) : 143 - 153
  • [34] Analysis of breast cancer drug treatment in Russia
    Derkach, E.
    Avxentyeva, M.
    Tarakanov, A.
    Bogin, V.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S137 - S137
  • [35] Drug therapy - Tamoxifen in the treatment of breast cancer
    Osborne, CK
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22): : 1609 - 1618
  • [36] Toremifene, a novel antiestrogen, can overcome hsp27-induced drug resistance in human breast cancer cells
    Mahvi, DM
    Carper, SW
    Yu, CO
    McCausland, TA
    Storm, FK
    ENDOCRINE, 1996, 4 (03): : 269 - 275
  • [37] Toremifene and breast cancer therapy: incidence of secondary endometrial cancers.
    Erkkola, R
    Nevala, P
    Mantyla, E
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156
  • [38] Therapeutic effect and basic research on high-dose toremifene to reduce anticancer drug resistance in breast cancer.
    Kusama, M
    Kaise, H
    Ota, D
    Aoki, T
    Kuroiwa, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 89S - 89S
  • [39] Breast cancer drug proposed as treatment for bladder cancer patients
    Jones, Sarah
    PHARMACOGENOMICS, 2014, 15 (04) : 412 - 413
  • [40] Cancer drug related cardiotoxicity during breast cancer treatment
    Giordano, Guido
    Spagnuolo, Alessia
    Olivieri, Nunzio
    Corbo, Claudia
    Campagna, Angelo
    Spagnoletti, Ilaria
    Pennacchio, Roberta Maria
    Campidoglio, Serena
    Pancione, Massimo
    Palladino, Luciano
    Villari, Bruno
    Febbraro, Antonio
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (08) : 1063 - 1074
12345